InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (9 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
9
T+90 hit rate
44%
T+90 mean return
-1.6%
Across 9 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Bhatia Sangeeta N., Director. Director active across 2 companies, notably Vertex Pharmaceuticals INC / MA. Aggregated, 18 disclosures have been logged. Split: 0 buy · 9 sells. Total volume traded: €587k. History available since 1 May 2021. The latest transaction was filed on 1 May 2025 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations18 total
796 shares0Common StockSEC:0000875320-25-000173:0
646 shares@ US$152.748.3% of flowCommon StockSEC:0000875320-24-000211:0
1,292 shares@ US$152.7416.8% of flowCommon StockSEC:0000875320-24-000204:0
1,001 shares0Common StockSEC:0000875320-24-000117:0
243 shares@ US$375.008.0% of flowCommon StockSEC:0001209191-23-053175:0
242 shares@ US$360.007.7% of flowCommon StockSEC:0001209191-23-052622:0
242 shares@ US$345.517.1% of flowCommon StockSEC:0000899243-23-018043:0
1,168 shares0Common StockSEC:0001209191-23-026991:0
621 shares@ US$310.0018.1% of flowCommon StockSEC:0000899243-22-034249:0
45 shares@ US$290.181.2% of flowCommon StockSEC:0000899243-22-028250:0
99 shares@ US$276.652.5% of flowCommon StockSEC:0000899243-22-027386:0
40 shares@ US$255.400.0000% mcap3.0% of flowCommon StockSEC:0000899243-22-016638:0
1,449 shares0Common StockSEC:0000899243-22-016337:0
1,907 shares@ US$125.710.0002% mcap67.3% of flowCommon StockSEC:0000899243-22-014549:0
285 shares@ US$208.960.0000% mcap14.9% of flowCommon StockSEC:0001209191-21-038182:0
285 shares@ US$208.964.5% of flowCommon StockSEC:0001209191-21-038182
1,842 shares0Common StockSEC:0001209191-21-029837:0
1,842 shares0Common StockSEC:0001209191-21-029837
18 of 18 declarations
About Bhatia Sangeeta N.
Sangeeta N. Bhatia serves as a Director at Vertex Pharmaceuticals Inc. In this role, she participates in the governance of the company and strategic decision-making. Her experience in the pharmaceutical sector is valuable for the organization's development.
